Takeda Pharmaceutical (TAK) Shares Outstanding (Entity) (2017 - 2026)
Takeda Pharmaceutical (TAK) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 834.66 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 167.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143.19 Mn |
| Sep 30, 2025 | 123.35 Mn |
| Mar 31, 2025 | 123.96 Mn |
| Sep 30, 2024 | 120.71 Mn |
| Mar 31, 2024 | 119.83 Mn |
| Dec 31, 2023 | 140.92 Mn |
| Sep 30, 2023 | 140.60 Mn |
| Jun 30, 2023 | 139.62 Mn |
| Mar 31, 2023 | 139.38 Mn |
| Dec 31, 2022 | 116.01 Mn |
| Sep 30, 2022 | 115.85 Mn |
| Jun 30, 2022 | 115.35 Mn |
| Mar 31, 2022 | 116.68 Mn |
| Dec 31, 2021 | 157.46 Mn |
| Sep 30, 2021 | 157.97 Mn |
| Jun 30, 2021 | 157.31 Mn |
| Mar 31, 2021 | 156.99 Mn |
| Dec 31, 2020 | 157.12 Mn |
| Sep 30, 2020 | 157.11 Mn |
| Jun 30, 2020 | 156.68 Mn |